AGC Chemicals Americas Inc. (AGCCA) and DRYFIBER LLC, announce the development and production launch of the industry’s first ...

Syensqo S.A. (Brussels, Belgium) announced a strategic partnership with Emulseo, a French company specialized in formulations for microfluidic technology ...

From left to right: Dr Tan Tong-De, Assoc Prof Koh Ming Joo and Ms Wang Yu-Qi from NUS Chemistry were key members of the multidisciplinary research team that developed the novel catalytic system to ...

Get Instant Summarized Text (Gist) A new catalytic transformation has been developed to convert epoxides into fluorinated oxetanes, a challenging class of drug molecules. This method uses a copper ...

The partnership with Emulseo will leverage Syensqo's Galden® PFPE, a family of inert, high-performance, fluorinated fluids with outstanding properties enabling optimal performances of microfluidic ...

Small, polar rings and electron-withdrawing atoms are both well-loved motifs in medicinal chemistry. So oxetanes and fluorine atoms could be a match made in drug discovery heaven. Researchers also ...

The partnership with Emulseo will leverage Syensqo's Galden® PFPE, a family of inert, high-performance, fluorinated fluids with outstanding properties enabling optimal performances of ...

BORDEAUX, France, Feb. 20, 2025 /PRNewswire/ -- Syensqo, a leading specialty chemicals company, is pleased to announce a strategic partnership with Emulseo, a French company specialized in ...

Novel method to synthesize valuable fluorinated drug compounds Date: February 21, 2025 Source: National University of Singapore Summary: Researchers have pioneered a new catalytic transformation ...